‘Inverse' vaccines may hold key to challenge autoimmune diseases
However, these injections work differently from conventional immunizations like the flu shot and currently available immunosuppressant treatments for autoimmune conditions.
They work by targeting only the specific part of the immune system that's behind diseases such as lupus, multiple sclerosis, psoriasis, rheumatoid arthritis and Type 1 diabetes, the experts say.
'Inverse vaccines are being developed to treat undesired immune responses, [and] for these situations, the body is reacting to something that is not dangerous,' said Lonnie Shea, a researcher in biomedical engineering at the University of Michigan who has studied inverse vaccines and worked on some of the key technology behind them.
'A vaccine activates an immune response to a specific antigen,' Shea told UPI via email. Inverse vaccines are being developed to treat undesired immune responses, [and] for these situations, the body is reacting to something that is not dangerous.
Essentially, an inverse vaccine 'aims to decrease the response to a specific antigen, like insulin in Type 1 diabetes,' he added.
First line of defense
When healthy, the immune system is the body's first line of defense against diseases such as cancer and infections caused by viruses and bacteria, according to the National Institutes of Health.
However, if the immune system isn't working properly, it can erroneously attack healthy cells, tissues and organs, causing autoimmune diseases that can affect any part of the body, weakening function and potentially leading to death, the NIH says.
More than 80 autoimmune diseases are known, some of which are caused by exposure to environmental toxins and have no discovered cure. At least 15 million people in the United States, or about 5% of the population, have an autoimmune disease, the agency reports.
Although no cure exists for these conditions, symptoms can be managed with drugs called immunosuppressants, which as the name suggests 'broadly reduces your immune system response,' Shea said.
These drugs, which are typically administered via monthly injections, can have significant side effects, including making those taking them more susceptible to infections, according to the NIH.
Many people taking them also have to be careful taking traditional vaccines, such as flu shot or COVID-19 shots because of their impact on the immune system.
Training the immune system
Developed by researchers at the University of Chicago and elsewhere, inverse vaccines use synthetic nanoparticles attached to specific disease-related proteins, or antigens, to train certain parts of the immune system to behave differently, limiting the attacks that cause autoimmune diseases, neurologist Dr. Lawrence Steinman said.
With the inverse vaccines currently being studied, the nanoparticles are designed to mimic human cell death, which is a normal process in the human body, according to the 2021 study that first documented their effectiveness in people with celiac disease, another autoimmune disorder.
Dying cells are considered foreign bodies, but the human immune system knows not to attack them.
As a result, with the nanoparticles in inverse vaccines, the immune system can be trained not to attack them, or the proteins attached to them, which effectively short-circuits the process behind autoimmune diseases, Steinman said.
'Instead of immunizing the recipient to a viral infection, the inverse vaccine tolerizes the immune system, so it will not attack our own tissues,' Steinman, who has written about inverse vaccines, told UPI in an email.
Several companies are running clinical trials of inverse vaccines, including Cour Pharma, which recently completed successful phase 2 clinical trials for their use in celiac disease and another autoimmune disease, primary biliary cholangitis, according to Shea at the University of Michigan, one of the researchers who started the company.
Additional trials -- phase 2 studies are the second stage in the drug research and development process -- are starting for myasthenia gravis and Type 1 diabetes, he added.
Although more research is needed before the shots become available, a process that could take five years or more, inverse vaccines offer key advantages, Shea said.
For example, unlike immunosuppressants with their monthly dosing, the effects of inverse vaccines appear to last longer, perhaps for as much as a year, similar to conventional vaccines, research suggests.
They may also work for people with severe, life-threatening allergies, such as peanut allergies, according to Shea, who has published a study in this area using mice.
However, there's also the 'risk that instead of tolerizing the human immune system to the target, the process induces conventional immunization, which would make autoimmune conditions like Type 1 diabetes and multiple sclerosis worse,' Steinman said.
However, 'We have come close to success in some early-stage trials,' he said 'Thus far, none of the results are sufficiently robust for submission in the FDA approval process.'
Copyright 2025 UPI News Corporation. All Rights Reserved.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Alcohol-related liver problems escalate in Wisconsin, especially for women, young people
Deaths from liver diseases that result from consuming too much alcohol are escalating dramatically in Wisconsin, and even more alarming, such diseases are showing up more in younger people. The numbers mirror national trends described in a June 11 study in JAMA Open Network, which found a "significant acceleration" in alcohol-associated liver disease deaths during and after the COVID-19 pandemic. Nationwide, such deaths increased nearly 9% annually between 2018 and 2022. In Wisconsin, deaths from cirrhosis of the liver — one of several liver diseases tied to alcohol consumption — rose 35% between 2019 and 2023, according to data from the Centers for Disease Control and Prevention. It's well-documented that Americans began drinking more during the pandemic, and coupled with Wisconsin's deeply entrenched drinking culture, experts worry about the toll they're seeing on people's physical health. Alcohol-related deaths generally, which include myriad other causes besides liver problems, increased three-fold in Wisconsin between 1999 and 2020, a January analysis from the Journal Sentinel found. But experts say multidisciplinary treatment, reduced stigma around alcohol use disorder, and a renewed emphasis on education and prevention could improve the situation. "I think the narrative often in Wisconsin is just, 'Oh, we're just big drinkers,' and that's all there is," said Maureen Busalacchi, director of the Wisconsin Alcohol Policy Project at the Medical College of Wisconsin. "The message is not that you can't drink at all. It's more, really think about it, and just drink less." More: Wisconsin's alcohol-related deaths more than tripled since 1999: See the data U.S. dietary guidelines for alcohol urge people of drinking age to limit consumption to one drink or fewer per day for women and two drinks or fewer per day for men. When people consume significant amounts of alcohol over a prolonged period of time, fat begins to turn up in the liver, and then scar tissue, which can lead to cirrhosis, said Dr. Rita German, a transplant hepatologist at UW Health in Madison. Many times, German said, liver disease symptoms such as jaundice, fever and confusion don't show themselves until the disease has progressed, making it harder to treat. Nearly 3,000 Wisconsinites died from alcohol-related liver diseases from 2019 to 2023, CDC data show. The large majority — 2,072 — were from cirrhosis. Deaths from most types of liver diseases due to alcohol consumption increased in those years, including alcoholic fatty liver and alcoholic hepatic failure in addition to cirrhosis. Deaths from alcoholic hepatitis fell slightly. Busalacchi called the numbers a huge concern. Most of these deaths are preventable, she contended. Doctors used to think of alcohol-related liver diseases as affecting people past middle age, German said. But increasingly, that age is dropping. At UW Health's multidisciplinary clinic for patients with such diseases, she said, the average age is now 45, and she's treated some as young as 25. More: Alcohol-related deaths in Wisconsin tripled since 1999. Will a new warning from the surgeon general slow the trend? That may seem to conflict with recent research showing young people, particularly Gen Z, drinking less. But while some are cutting back, those who do drink are drinking more heavily, Busalacchi said. And while alcohol use among Wisconsin high schoolers has generally decreased in recent years, more than one in 10 reported binge drinking in the last 30 days on the state's most recent Youth Risk Behavior Survey, done in 2023. The JAMA study noted, in particular, increases in alcohol-related liver disease deaths among adults ages 25-44. Deaths among women also increased disproportionately. Women absorb more alcohol into their bloodstream because they're generally smaller than men and because women's bodies have less gastric alcohol dehydrogenase, the enzyme that breaks down alcohol in the stomach, German said. Thus, they're at greater risk for liver damage. The Medical College of Wisconsin's liver transplant team reports younger and younger women needing transplants due to alcohol consumption, Busalacchi said. More: US to drop guidance to limit alcohol to one or two drinks per day, sources say To catch alcohol-related liver diseases earlier, German said, it's critical that patients be forthcoming about their alcohol use at the doctor's office. And for that to happen, she said, doctors must view alcohol use disorder for what it is — a disease, not a personal failing. People who are concerned about their alcohol consumption may also request an ultrasound of their liver, German said. From there, they can begin treatment if need be. She also sees the benefits in treatment that is comprehensive. At UW Health's clinic, patients not only see doctors like German who attend to the liver, but addiction specialists and counselors to treat underlying mental health conditions that can drive alcohol use. The clinic has treated between 250 and 300 people since it began in 2021. If it's caught in time, fat and scarring in the liver can be reversed by abstaining from alcohol, German said. Busalacchi's work continues to focus on changing societal perceptions on drinking culture. She sees encouraging signs around the state from communities that are offering more education about the consequences of excessive drinking, especially for youth. Some are taking a harder stance on age compliance checks for alcohol sales. Madeline Heim covers health and the environment for the Milwaukee Journal Sentinel. Contact her at 920-996-7266 or mheim@ This article originally appeared on Milwaukee Journal Sentinel: Wisconsin deaths from alcohol-related liver diseases sharply rise
UPI
an hour ago
- UPI
NASA discovers third interstellar comet
NASA discovered the third interstellar comet through a survey telescope in Rio Hurtado,Chile on Monday .File Photo by Aaron M. Sprecher/UPI | License Photo July 3 (UPI) -- NASA discovered the third interstellar comet through a survey telescope in Rio Hurtado, Chile. The interstellar comet first observed on Tuesday by NASA's Asteroid Terrestrial-impact Alert System telescope, or ATLAS, has been officially named 3I/ATLAS. A series of "pre-discovery" observations dating back to June 14 from three ATLAS Telescopes globally and the Zwicky Transient Facility in California's Palomar Observatory have since been collected, along with new observations from several telescopes since the initial report. "If confirmed, it will be the third known interstellar object from outside our solar system that we have discovered," Dr. Mark Norris, a senior lecturer in astronomy at the University of Central Lancashire, told The Guardian. Dr. Paul Chodas, director of the Center for Near Earth Object Studies at NASA's Jet Propulsion Laboratory in California, told The New York Times there is "no uncertainty" that the comet is from interstellar space, noting speeds that indicate it could not have originated in our solar system. "If you trace its orbit backward, it seems to be coming from the center of the galaxy, more or less," Chodas said. "It definitely came from another solar system. We don't know which one." The comet will reach its closest approach to the Sun around Oct. 30, but it shows no threat to Earth as it will remain at least 150 million miles away. It is currently about 416 million miles from the Sun. In December, the comet is expected to reappear on the other side of the Sun. The comet's size and physical attributes are being investigated. It is expected to remain visible to ground-based telescopes through September. Jake Foster, a Royal Observatory Greenwich astronomer, said: "At the moment, the comet is not expected to be visible to the naked eye, but it should be visible through a reasonably sized amateur telescope in late 2025 and early 2026. As it is studied more over the coming weeks, we'll get a better idea of just how visible it will realistically be." In 2017 Oumunamua traveled through the solar system as the first interstellar object. In 2019, the second interstellar comet, Borisov passed by.
UPI
an hour ago
- UPI
Medicaid cuts would leave the working class more vulnerable
The Congressional Budget Office estimates that 7.8 million Americans across the United States would lose their coverage through Medicaid -– the public program that provides health insurance to low-income families and individuals -– under the One Big Beautiful Bill Act making its way through Congress. Photo by Jonathan Borb/ Pexels The Congressional Budget Office estimates that 7.8 million Americans across the United States would lose their coverage through Medicaid -- the public program that provides health insurance to low-income families and individuals -- under the One Big Beautiful Bill Act making its way through Congress. That includes 248,000 to 414,000 of my fellow residents of Michigan, based on the House Reconciliation Bill in early June 2025. There are similarly deep projected cuts within the Senate version of the legislation. Many of these people are working Americans who would lose Medicaid because of the onerous paperwork involved with the proposed work requirements. They wouldn't be able to get coverage in the Affordable Care Act Marketplaces after losing Medicaid. Premiums and out-of-pocket costs are likely to be too high for those making less than 100% to 138% of the federal poverty level who do not qualify for health insurance marketplace subsidies. Funding for this program is also under threat. And despite being employed, they also wouldn't be able to get health insurance through their employers because it is either too expensive or not offered to them. Researchers estimate that coverage losses would lead to thousands of medically preventable deaths across the country because people would be unable to access health care without insurance. I am a physician, health economist and policy researcher who has cared for patients on Medicaid and written about health care in the United States for more than eight years. I think it's important to understand the role of Medicaid within the broader insurance landscape. Medicaid has become a crucial source of health coverage for low-wage workers. Michigan removed work requirements from Medicaid A few years ago, Michigan was slated to institute Medicaid work requirements, but the courts blocked the implementation of that policy in 2020. It would have cost upward of $70 million due to software upgrades, staff training, and outreach to Michigan residents enrolled in the Medicaid program, according to the Michigan Department of Health and Human Services. Had it gone into effect, 100,000 state residents were expected to lose coverage within the first year. The state took the formal step of eliminating work requirements from its statutes earlier this year in recognition of implementation costs being too high and mounting evidence against the policy's effectiveness. When Arkansas instituted Medicaid work requirements in 2018, there was no increase in employment, but within months, thousands of people enrolled in the program lost their coverage. The reason? Many people were subjected to paperwork and red tape, but there weren't actually that many people who would fail to meet the criteria of the work requirements. It is a recipe for widespread coverage losses without meeting any of the policy's purported goals. Work requirements, far from incentivizing work, paradoxically remove working people from Medicaid with nowhere else to go for insurance. Shortcomings of employer-sponsored insurance Nearly half of Americans get their health insurance through their employers. In contrast to a universal system that covers everyone from cradle to grave, an employer-first system leaves huge swaths of the population uninsured. This includes tens of millions of working Americans who are unable to get health insurance through their employers, especially low-income workers who are less likely to even get the choice of coverage from their employers. More than 80% of managers and professionals have employer-sponsored health coverage, but only 50% to 70% of blue-collar workers in service jobs, farming, construction, manufacturing and transportation can say the same. There are some legal requirements mandating employers to provide health insurance to their employees, but the reality of low-wage work means many do not fall under these legal protections. For example, employers are allowed to incorporate a waiting period of up to 90 days before health coverage begins. The legal requirement also applies only to full-time workers. Health coverage can thus remain out of reach for seasonal and temporary workers, part-time employees and gig workers. Even if an employer offers health insurance to their low-wage employees, those workers may forego it because the premiums and deductibles are too high to make it worth earning less take-home pay. To make matters worse, layoffs are more common for low-wage workers, leaving them with limited options for health insurance during job transitions. And many employers have increasingly shed low-wage staff, such as drivers and cleaning staff, from their employment rolls and contracted that work out. Known as the fissuring of the workplace, it allows employers of predominately high-income employees to continue offering generous benefits while leaving no such commitment to low-wage workers employed as contractors. Medicaid fills in gaps Low-income workers without access to employer-sponsored insurance had virtually no options for health insurance in the years before key parts of the Affordable Care Act went into effect in 2014. Research my co-authors and I conducted showed that blue-collar workers have since gained health insurance coverage, cutting the uninsured rate by a third thanks to the expansion of Medicaid eligibility and subsidies in the health insurance marketplaces. This means low-income workers can more consistently see doctors, get preventive care and fill prescriptions. Further evidence from Michigan's experience has shown that Medicaid can help the people it covers do a better job at work by addressing health impairments. It can also improve their financial well-being, including fewer problems with debt, fewer bankruptcies, higher credit scores and fewer evictions. Premiums and cost sharing in Medicaid are minimal compared with employer-sponsored insurance, making it a more realistic and accessible option for low-income workers. And because Medicaid is not tied directly to employment, it can promote job mobility, allowing workers to maintain coverage within or between jobs without having to go through the bureaucratic complexity of certifying work. Of course, Medicaid has its own shortcomings. Payment rates to providers are low relative to other insurers, access to doctors can be limited, and the program varies significantly by state. But these weaknesses stem largely from underfunding and political hostility - not from any intrinsic flaw in the model. If anything, Medicaid's success in covering low-income workers and containing per-enrollee costs points to its potential as a broader foundation for health coverage. The current employer-based system, which is propped up by an enormous and regressive tax break for employer-sponsored insurance premiums, favors high-income earners and contributes to wage stagnation. In my view, which is shared by other health economists, a more public, universal model could better cover Americans regardless of how someone earns a living. Over the past six decades, Medicaid has quietly stepped into the breach left by employer-sponsored insurance. Medicaid started as a welfare program for the needy in the 1960s, but it has evolved and adapted to fill the needs of a country whose health care system leaves far too many uninsured. Sumit Agarwal is an assistant professor of internal medicine at the University of Michigan. This article is republished from The Conversation under a Creative Commons license. Read the original article. The views and opinions in this commentary are solely the views of the author.
